These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 31345187)

  • 1. Impact of age on the use of adjuvant treatments in patients undergoing surgery for colorectal cancer: patients with stage III colon or stage II/III rectal cancer.
    Sarasqueta C; Perales A; Escobar A; Baré M; Redondo M; Fernández de Larrea N; Briones E; Piera JM; Zunzunegui MV; Quintana JM;
    BMC Cancer; 2019 Jul; 19(1):735. PubMed ID: 31345187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Comorbidities in Stage II/III Colorectal Cancer Patients Treated With Surgery and Neoadjuvant/Adjuvant Chemotherapy: A Single-Center, Observational Study.
    Baretti M; Rimassa L; Personeni N; Giordano L; Tronconi MC; Pressiani T; Bozzarelli S; Santoro A
    Clin Colorectal Cancer; 2018 Sep; 17(3):e489-e498. PubMed ID: 29650416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of treatment received versus long-standing guidelines for stage III colon and stage II/III rectal cancer patients diagnosed in Alberta, Saskatchewan, and Manitoba in 2004.
    Cree M; Tonita J; Turner D; Nugent Z; Alvi R; Barss R; King C; Winget M
    Clin Colorectal Cancer; 2009 Jul; 8(3):141-5. PubMed ID: 19632928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of surgery and adjuvant therapy in older patients with colorectal cancer: a STROBE-compliant article.
    Yang L; Ma Q; Yu YY; Wang C; Meng WJ; Adell G; Albertsson M; Arbman G; Jarlsfelt I; Peng ZH; Li Y; Zhou ZG; Sun XF
    Medicine (Baltimore); 2014 Dec; 93(28):e266. PubMed ID: 25526455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benefit of Postresection Adjuvant Chemotherapy for Stage III Colon Cancer in Octogenarians: Analysis of the National Cancer Database.
    Bergquist JR; Thiels CA; Spindler BA; Shubert CR; Hayman AV; Kelley SR; Larson DW; Habermann EB; Pemberton JH; Mathis KL
    Dis Colon Rectum; 2016 Dec; 59(12):1142-1149. PubMed ID: 27824699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of Long-Term Quality of Life for Survivors of Stage II/III Rectal Cancer in the Cancer Care Outcomes Research and Surveillance Consortium.
    Charlton ME; Stitzenberg KB; Lin C; Schlichting JA; Halfdanarson TR; Juarez GY; Pendergast JF; Chrischilles EA; Wallace RB
    J Oncol Pract; 2015 Jul; 11(4):e476-86. PubMed ID: 26080831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adherence to treatment guidelines and survival for older patients with stage II or III colon cancer in Texas from 2001 through 2011.
    Zhao H; Zhang N; Ho V; Ding M; He W; Niu J; Yang M; Du XL; Zorzi D; Chavez-MacGregor M; Giordano SH
    Cancer; 2018 Feb; 124(4):679-687. PubMed ID: 29140558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does patient age still affect receipt of adjuvant therapy for colorectal cancer in New South Wales, Australia?
    Jorgensen ML; Young JM; Dobbins TA; Solomon MJ
    J Geriatr Oncol; 2014 Jul; 5(3):323-30. PubMed ID: 24656735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival among clinical stage I-III rectal cancer patients treated with different preoperative treatments: A population-based comparison.
    Joye I; Silversmit G; Van Eycken E; Debucquoy A; Vandendael T; Penninckx F; Haustermans K
    Cancer Epidemiol; 2016 Aug; 43():35-41. PubMed ID: 27388565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant Chemotherapy After Preoperative Chemoradiation Improves Survival in Patients With Locally Advanced Rectal Cancer.
    Sun Z; Gilmore B; Adam MA; Kim J; Hsu SD; Migaly J; Mantyh CR
    Dis Colon Rectum; 2017 Oct; 60(10):1050-1056. PubMed ID: 28891848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized Clinical Trials in Colon and Rectal Cancer.
    Iqbal A; George TJ
    Surg Oncol Clin N Am; 2017 Oct; 26(4):689-704. PubMed ID: 28923225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gender differences in stage at diagnosis and preoperative radiotherapy in patients with rectal cancer.
    Sarasqueta C; Zunzunegui MV; Enríquez Navascues JM; Querejeta A; Placer C; Perales A; Gonzalez N; Aguirre U; Baré M; Escobar A; Quintana JM;
    BMC Cancer; 2020 Aug; 20(1):759. PubMed ID: 32795358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Underutilization or appropriate care? Assessing adjuvant chemotherapy use and survival in 3 heterogenous subpopulations with stage II/III colorectal cancer within a large integrated health system.
    Chen Y; Shankaran V; Hahn EE; Haupt EC; Bansal A
    J Manag Care Spec Pharm; 2023 Jun; 29(6):635-646. PubMed ID: 37276035
    [No Abstract]   [Full Text] [Related]  

  • 14. Adherence to treatment guidelines in stage II/III rectal cancer in Alberta, Canada.
    Eldin NS; Yasui Y; Scarfe A; Winget M
    Clin Oncol (R Coll Radiol); 2012 Feb; 24(1):e9-17. PubMed ID: 21802914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant Chemotherapy Seemed Not to Have Survival Benefit in Rectal Cancer Patients with ypTis-2N0 After Preoperative Radiotherapy and Surgery from a Population-Based Propensity Score Analysis.
    Hu X; Li YQ; Li QG; Ma YL; Peng JJ; Cai SJ
    Oncologist; 2019 Jun; 24(6):803-811. PubMed ID: 29674444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative treatment selection in rectal cancer: a population-based cohort study.
    Elliot AH; Martling A; Glimelius B; Nordenvall C; Johansson H; Nilsson PJ
    Eur J Surg Oncol; 2014 Dec; 40(12):1782-8. PubMed ID: 25260598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between right-sided tumour location, tumour microenvironment, systemic inflammation, adjuvant therapy and survival in patients undergoing surgery for colon and rectal cancer.
    Patel M; McSorley ST; Park JH; Roxburgh CSD; Edwards J; Horgan PG; McMillan DC
    Br J Cancer; 2018 Mar; 118(5):705-712. PubMed ID: 29337962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controversial Issues Regarding Obligatory Adjuvant Chemotherapy for Stage IIIA Colon Cancer.
    Kim CW; Kim TW; Lee JL; Park IJ; Yoon YS; Lim SB; Yu CS; Kim JC
    Clin Colorectal Cancer; 2020 Dec; 19(4):e157-e163. PubMed ID: 32896486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of surgical procedures and adjuvant therapy in rectal cancer treatment: a population-based study.
    Schroen AT; Cress RD
    Ann Surg; 2001 Nov; 234(5):641-51. PubMed ID: 11685027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poor compliance with adjuvant chemotherapy use associated with poorer survival in patients with rectal cancer: An NCDB analysis.
    Xu Z; Mohile SG; Tejani MA; Becerra AZ; Probst CP; Aquina CT; Hensley BJ; Arsalanizadeh R; Noyes K; Monson JR; Fleming FJ
    Cancer; 2017 Jan; 123(1):52-61. PubMed ID: 27560162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.